Search

The ANZCHOG-BN was developed to improve and streamline access to high quality pediatric and adolescent/young adult cancer biospecimens for cancer research

We discovered a previously unknown major resistance mechanism in glioma in that most EGFR domain III-targeting antibodies do not neutralize EGFRvIII

We present a curated panel of 12 readily-usable, cell lines representing the spectrum of molecular subtypes of IDH-wildtype glioblastoma

Bevacizumab is well tolerated and appears most effective for rapid tumor control to preserve vision and improve morbidity

This multi-center study provides valuable information on the success rate of establishing patient-derived pre-clinical models of diffuse intrinsic pontine glioma

This chapter summarizes recent advances in diffuse intrinsic pontine glioma and potential novel therapies

We provide evidence that targeting leukemia-induced bone loss is a therapeutic strategy for pre-B ALL

Here we report that CHAF1B is required for normal hematopoiesis while its overexpression promotes leukemia

A novel mouse model for glioma demonstrating that the PI3K pathway is important for initiation of tumorigenesis

This study demonstrates that exercise is achievable and has positive effects on vascular function, submaximal fitness, local strength and physical activity in a population of AYA survivors of pediatric oncology related cerebral insult